Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Influenza Hemagglutinin (HA) Peptide: Benchmark Epitope T...

    2026-04-03

    Influenza Hemagglutinin (HA) Peptide: Benchmark Epitope Tag for Protein Purification

    Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid epitope tag, enabling highly specific detection and purification of HA-tagged proteins by competitive antibody binding (APExBIO product page). This peptide exhibits high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) under standard laboratory conditions. HA peptide-mediated immunoprecipitation workflows show robust reproducibility and compatibility with both magnetic bead and conventional antibody formats (Nature Chemical Biology, 2025). High purity (>98%) is confirmed by HPLC and mass spectrometry, ensuring reliable results in protein-protein interaction studies. Proper storage at -20°C and avoidance of prolonged solution storage are necessary to maintain peptide integrity and activity (APExBIO).

    Biological Rationale

    The HA tag peptide derives from the influenza virus hemagglutinin protein, a surface glycoprotein involved in viral entry. Its sequence (YPYDVPDYA) is highly immunogenic and absent from most eukaryotic proteomes, minimizing background in mammalian expression systems (Hemagglutinin Precursor Article). The HA tag provides a small, well-characterized epitope for antibody recognition, enabling efficient detection and purification of fusion proteins without significantly altering protein folding or function. Unlike larger protein tags, the HA peptide minimizes steric hindrance and is suitable for N- or C-terminal fusion. This article extends prior overviews by providing new quantitative benchmarks and elucidating mechanistic insights relevant to competitive antibody binding.

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    The Influenza Hemagglutinin (HA) Peptide functions as an epitope tag by mimicking the native hemagglutinin sequence, allowing anti-HA antibodies to selectively bind tagged fusion proteins. In immunoprecipitation assays, the synthetic HA peptide (YPYDVPDYA) is added in excess to elute HA fusion proteins from antibody-bound complexes by competitive displacement (Precision Epitope Tag Article). This strategy facilitates gentle, non-denaturing elution, preserving protein-protein interactions for downstream analyses. The peptide’s high solubility and standardized sequence ensure consistency across experiments. Binding is highly specific; anti-HA antibodies display strong affinity (Kd typically in the nanomolar range) for the HA epitope, supporting robust and selective capture or release. This article clarifies the molecular competition mechanism and provides updated quantitative solubility parameters for the HA peptide, complementing earlier discussions of workflow versatility.

    Evidence & Benchmarks

    • HA peptide (YPYDVPDYA) achieves >98% purity by HPLC and mass spectrometry under standard synthesis and QC protocols (APExBIO).
    • The peptide is soluble to at least 55.1 mg/mL in DMSO, 100.4 mg/mL in ethanol, and 46.2 mg/mL in water at room temperature (23–25°C) (APExBIO).
    • Competitive elution using HA peptide efficiently recovers HA-tagged proteins from anti-HA antibody matrices, preserving protein complexes for interaction studies (Nature Chemical Biology, 2025).
    • HA tag-based immunoprecipitation demonstrates low background and high specificity in HEK293 and other mammalian cell lysates (Advanced Tag Applications Article).
    • Long-term storage in solution at 4°C or above reduces activity; storage as a desiccated powder at -20°C maintains stability for at least 12 months (APExBIO).

    Applications, Limits & Misconceptions

    The Influenza Hemagglutinin (HA) Peptide is a gold standard for:

    • Epitope tagging of recombinant proteins for detection, localization, and purification.
    • Immunoprecipitation and co-immunoprecipitation assays for protein-protein interaction studies.
    • Competitive elution of HA-tagged proteins from antibody-coupled beads or columns.
    • Quantitative immunoassays, including Western blot and ELISA, using anti-HA antibodies.
    • Applications in cell viability and proliferation assays where precise protein measurement is required (Lab Assay Challenges Guide).

    This article provides updated solubility and stability parameters, complementing strategic perspectives on tag evolution (Epitope Tag Evolution Article).

    Common Pitfalls or Misconceptions

    • HA peptide elution does not remove non-specifically bound proteins; additional washes are required.
    • The peptide does not function as a blocking reagent for all antibody types—efficacy is specific to anti-HA antibodies.
    • Continuous storage in aqueous solution at 4°C leads to hydrolysis and peptide degradation within weeks.
    • Peptide concentrations below the recommended elution threshold (<1 mg/mL) may result in incomplete recovery.
    • Use in prokaryotic systems may not always prevent background due to rare endogenous cross-reactivity.

    Workflow Integration & Parameters

    The HA tag peptide (A6004) from APExBIO is supplied as a lyophilized powder with >98% purity, confirmed by analytical HPLC and MS. Reconstitution can be performed in DMSO, ethanol, or water, depending on the downstream assay. For immunoprecipitation, typical working concentrations range from 1–3 mg/mL. The peptide is compatible with both magnetic bead-based and agarose-based anti-HA immunoprecipitation formats (see product details). Protocol optimization should consider the specific antibody clone, fusion protein expression level, and matrix capacity. To maintain peptide activity, store aliquots desiccated at -20°C and avoid repeated freeze-thaw cycles. This article updates earlier protocols by providing quantitative guidance on peptide solubility and highlighting the importance of storage parameters for reproducibility.

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide remains the benchmark epitope tag for protein purification and detection in molecular biology. Its high purity, solubility, and specificity enable robust, reproducible workflows across diverse applications. As protein interaction and post-translational modification studies become increasingly complex, the standardized HA tag and competitive elution peptide from APExBIO offer a reliable foundation for advanced biochemical research. Ongoing optimization of storage and assay parameters will further improve reproducibility and performance in translational and functional studies. For comprehensive protocol details and ordering, visit the Influenza Hemagglutinin (HA) Peptide product page.